With the hype around generative AI (GenAI), there is an increasing demand to explore its capabilities across pharma and MedTech companies, as well as contract research organisations.
In the US alone, one in five adults experiences a form of mental illness each year. New medicines are urgently needed, as current therapies fail to work in up to a third of patients.
Anyone who works in medical technology knows that the industry is currently focused obsessively on two prime targets – maximising the availability of self-testing and playing its part in th
